GB201116010D0 - Use of alginate oligomers to enhance the effects of antifungal agents - Google Patents

Use of alginate oligomers to enhance the effects of antifungal agents

Info

Publication number
GB201116010D0
GB201116010D0 GBGB1116010.8A GB201116010A GB201116010D0 GB 201116010 D0 GB201116010 D0 GB 201116010D0 GB 201116010 A GB201116010 A GB 201116010A GB 201116010 D0 GB201116010 D0 GB 201116010D0
Authority
GB
United Kingdom
Prior art keywords
enhance
effects
antifungal agents
alginate oligomers
oligomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1116010.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Algipharma AS
Original Assignee
Algipharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algipharma AS filed Critical Algipharma AS
Priority to GBGB1116010.8A priority Critical patent/GB201116010D0/en
Publication of GB201116010D0 publication Critical patent/GB201116010D0/en
Priority to JP2014530315A priority patent/JP6182141B2/ja
Priority to US14/345,224 priority patent/US20150126467A1/en
Priority to EP12766466.2A priority patent/EP2755481B1/en
Priority to ES12766466T priority patent/ES2798775T3/es
Priority to PCT/GB2012/052274 priority patent/WO2013038197A1/en
Priority to DK12766466.2T priority patent/DK2755481T3/da
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/04—Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GBGB1116010.8A 2011-09-15 2011-09-15 Use of alginate oligomers to enhance the effects of antifungal agents Ceased GB201116010D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB1116010.8A GB201116010D0 (en) 2011-09-15 2011-09-15 Use of alginate oligomers to enhance the effects of antifungal agents
JP2014530315A JP6182141B2 (ja) 2011-09-15 2012-09-14 抗真菌剤の効果を高めるアルギネートオリゴマーの使用
US14/345,224 US20150126467A1 (en) 2011-09-15 2012-09-14 Use of alginate oligomers to enhance the effects of antifungal agents
EP12766466.2A EP2755481B1 (en) 2011-09-15 2012-09-14 Use of alginate oligomers to enhance the effects of antifungal agents
ES12766466T ES2798775T3 (es) 2011-09-15 2012-09-14 Uso de oligómeros de alginato para reforzar los efectos de agentes antifúngicos
PCT/GB2012/052274 WO2013038197A1 (en) 2011-09-15 2012-09-14 Use of alginate oligomers to enhance the effects of antifungal agents
DK12766466.2T DK2755481T3 (da) 2011-09-15 2012-09-14 Anvendelse af alginatoligomerer til at forøge virkningerne af svampemidler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1116010.8A GB201116010D0 (en) 2011-09-15 2011-09-15 Use of alginate oligomers to enhance the effects of antifungal agents

Publications (1)

Publication Number Publication Date
GB201116010D0 true GB201116010D0 (en) 2011-10-26

Family

ID=44908661

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1116010.8A Ceased GB201116010D0 (en) 2011-09-15 2011-09-15 Use of alginate oligomers to enhance the effects of antifungal agents

Country Status (7)

Country Link
US (1) US20150126467A1 (https=)
EP (1) EP2755481B1 (https=)
JP (1) JP6182141B2 (https=)
DK (1) DK2755481T3 (https=)
ES (1) ES2798775T3 (https=)
GB (1) GB201116010D0 (https=)
WO (1) WO2013038197A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150132585A (ko) * 2013-03-22 2015-11-25 요우이치 미즈타 식물 조직의 배양용 배지의 제조 방법 및 식물 조직의 배양 방법 및 멸균 처리제, 살균 처리제, 및 식물 조직 배양용 배지 조성물
KR101870846B1 (ko) * 2013-05-30 2018-06-25 수저우 시스케이프 바이오메디신 사이언스 앤드 테크놀로지 컴퍼니 리미티드 다기능성 조성물 및 이의 제조 방법과 용도
CN104435823B (zh) * 2014-11-14 2018-02-27 西藏月王藏药科技有限公司 一种青稞红曲藏药饮片的制备方法
WO2018127819A1 (en) 2017-01-03 2018-07-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
JP7112706B2 (ja) * 2017-01-16 2022-08-04 御木本製薬株式会社 抗菌性組成物並びに該抗菌性組成物を配合した皮膚外用剤
US10548948B2 (en) * 2017-03-02 2020-02-04 The United States Of America As Represented By The Secretary Of The Navy Methods of treating fungal infections
JP7403152B2 (ja) 2017-03-28 2023-12-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景
EP3710514B1 (en) 2017-11-15 2023-06-07 The University of North Carolina at Chapel Hill Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto
CN107904179B (zh) * 2017-12-18 2020-10-23 云南天禾地生物科技股份有限公司 一株兼具植物促生长和抗病性的罗伦隐球酵母及其应用
CA3091458A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
WO2019180047A1 (en) * 2018-03-19 2019-09-26 Algipharma As Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers
CN113383019B (zh) 2018-12-28 2023-11-17 北卡罗来纳大学教堂山分校 一氧化氮释放型抗菌聚合物和由其制成的支架和其相关方法
EP3841248A4 (en) * 2019-04-08 2022-05-04 Main Choice Paper Products Limited GERMAN BOOK AND FOOD PAPER PACKAGING AND METHOD OF MANUFACTURE
EP3837977A1 (en) 2019-12-19 2021-06-23 Université de Bourgogne Use of alginates oligomers to improve plant protection against pathogens
DE102020101110A1 (de) 2020-01-17 2021-07-22 Beuth Hochschule Für Technik Berlin Antimykotische Aktivitäten von Hydrogelen auf Basis von Polysacchariden
CN111701013A (zh) * 2020-07-02 2020-09-25 深圳市恩瑜生物科技有限公司 一种具有治疗真菌感染的外用药物及制备方法
CN113430125B (zh) * 2021-07-27 2022-11-08 塔里木大学 一种高酯化力与糖化力的混合菌剂及其培养方法
CN114009440A (zh) * 2021-11-22 2022-02-08 兰州大学 阿巴芬净在防治农业病原菌中的用途
US20230346101A1 (en) * 2022-04-29 2023-11-02 Distinct Dermatology Inc. Treatment of fungal nail infection
WO2026008878A1 (en) * 2024-07-04 2026-01-08 Algipharma As Antimycotic polyene-alginate oligomer conjugates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011205A1 (en) 1990-01-23 1991-08-08 Trancel Corporation Mannuronic acid containing alginate wound healing composition and method
US5169840A (en) 1991-03-27 1992-12-08 Nobipols Forskningsstiftelse Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
US5217493A (en) * 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
CA2106609A1 (en) 1992-09-28 1994-03-29 Irene Yeatman Aldridge Proteases to inhibit and remove biofilm
GB9221163D0 (en) 1992-10-08 1992-11-25 Nobipol And Protan Biopolymer Dna compounds
JPH093031A (ja) * 1995-04-17 1997-01-07 Mitsubishi Chem Corp ヒドロキサム酸誘導体並びにそれを含有する農園芸用殺菌剤
EP0807631B1 (en) * 1996-05-15 2003-03-12 Sankyo Company Limited Tricyclic compounds having fungicidal activity, their preparation and their use
NO305033B1 (no) 1997-05-09 1999-03-22 Algipharma As Fremgangsmate for fremstilling av uronsyreblokker fra alginat
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
NO326145B1 (no) 2001-11-30 2008-10-06 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning hos pattedyr, fugler og krypdyr.
NO20023581D0 (no) 2002-07-26 2002-07-26 Fmc Biopolymer As Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
GB2430881B (en) 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
HUE034051T2 (en) * 2007-11-27 2018-01-29 Algipharma As Use of alginate-containing oligomers to combat biofilms

Also Published As

Publication number Publication date
DK2755481T3 (da) 2020-06-15
EP2755481A1 (en) 2014-07-23
WO2013038197A1 (en) 2013-03-21
US20150126467A1 (en) 2015-05-07
EP2755481B1 (en) 2020-03-18
JP6182141B2 (ja) 2017-08-16
ES2798775T3 (es) 2020-12-14
JP2014527079A (ja) 2014-10-09

Similar Documents

Publication Publication Date Title
GB201116010D0 (en) Use of alginate oligomers to enhance the effects of antifungal agents
ZA201404078B (en) Bradyrhizobium strains
ZA201401723B (en) N-thio-anthranilamide compounds and their use as pesticides
EP2681336A4 (en) ENHANCED BIODISTRIBUTION OF OLIGOMERS
IL233756A0 (en) New treatment factors
PL3701800T3 (pl) Zastosowanie
GB201216800D0 (en) Novel use
ZA201406082B (en) Use of ccr3-inhibitors
GB201111630D0 (en) Novel compounds and their use
GB201003218D0 (en) Improvements relating to platform devices
GB201104001D0 (en) Improvements to goggles
IL237798A0 (en) Methods for treating persimmons
GB2507762B (en) Improvements to dartboards
GB201212463D0 (en) Novel use
GB201102289D0 (en) New use
GB201100529D0 (en) Improvements in or relating to drying devices
GB201113490D0 (en) The easier way to make pans
GB201100489D0 (en) Improvements relating to retail devices
GB201110062D0 (en) Improvements to liquid sprays and combined applications
GB201103770D0 (en) Novel use
GB201108947D0 (en) Novel use
GB201105710D0 (en) Improvements relating to drying devices
TWM385984U (en) Walker structure
GB201220690D0 (en) Improvements relating to pasteurisation
GB201119436D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)